Skip to main content

Managing Access to Anti-VEGF Therapies for Retina Clinics

Regeneron is proud to provide this educational program to support retina specialists and clinic staff.

Click here to view available resources or scroll down to learn more.
Designed for busy clinicians and staff, self-study micromodules cover:

Drug acquisition and billing processes

Insurance benefit design and reimbursement dynamics

Drug supply chain

Payer utilization management

Operational considerations for access to anti-VEGF therapies

Program objectives:

  • Enhance knowledge of retina access dynamics to help improve treatment options like anti-VEGF therapies
  • Provide education to inform on potential patient access barriers in the treatment of retinal disease
  • Deliver critical insights to help navigate impact of market changes on patient care

Start your journey here

Introduction to Managing Access to Anti-VEGF Therapies: An Educational Series for Retina Clinics

This module introduces the program and provides basic information on how to select modules and navigate the material.
Download

After reviewing the introductory module, select modules below based on your interest or educational need.

Please click below to view and download each on-demand interactive module.

Anti-VEGFs and the Retina Clinic Treatment Model
Modules 1-3

Overview of Treatments and
Reimbursement Considerations
Within the Anti-VEGF Landscape

This module provides an overview of important concepts to the anti-VEGF landscape, including:

  • Evolution of available anti-VEGF treatments
  • Insurance provider strategies
  • Insurance provider contract impact on retina clinic
Download

Drug Acquisition in the Clinic

This module reviews models for and implications of anti-VEGF drug acquisition, including:

  • Overview of insurance types, specialty pharmacy, and medical benefit
  • Highlights of the buy-and-bill model
  • Impact of buy-and-bill on clinic revenue cycle management
Download

Considerations for the Use of Anti-VEGF Agents in the Retina Clinic

This module highlights information related to the use of anti-VEGF therapies, including:

  • Involvement of various stakeholders
  • Clinical and reimbursement considerations impacting therapy selection
  • Important considerations for retina clinic decision makers
Download

Understanding and Managing Patient Access to Therapy
Modules 4 & 5

Managing Patient Access to Therapy

This module highlights information on patient access to anti-VEGF therapies, including:

  • Steps required to help secure patient access and reimbursement
Download

Benefit Design and Medical Policy Impact on Access for Patients

This module establishes foundational knowledge about patient insurance benefit design and its relevance for access to anti-VEGF therapy, including:

  • Overview of the pharmacy benefit, pharmacy benefit manager role, utilization management, and drug rebates
  • Overview of the medical benefit and the buy-and-bill drug acquisition model
  • Advantages and disadvantages of the buy-and-bill model for retina specialists managing patient access to anti-VEGF therapy
Download

Regeneron encourages you to review these modules at your convenience and reach out if you would like to discuss them further. We welcome your feedback and input on information that supports your clinic in managing patient care.

For more information, reach out to your Regeneron contact or email oph.marketaccess@regeneron.com

The modules are provided for informational purposes only, are subject to change, and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect the services and products furnished to a specific patient.